UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025594
Receipt number R000029455
Scientific Title Effect of tolvaptan in the early post operative period after cardiac surgery
Date of disclosure of the study information 2017/01/11
Last modified on 2018/05/09 09:52:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of tolvaptan in the early post operative period after cardiac surgery

Acronym

Effect of tolvaptan after cardiac surgery

Scientific Title

Effect of tolvaptan in the early post operative period after cardiac surgery

Scientific Title:Acronym

Effect of tolvaptan after cardiac surgery

Region

Japan


Condition

Condition

Patients undergoing cardiac surgery using cardiopulmonary bypass

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will investigate the effect of tolvaptan for early postoperative period after cardiac surgery

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Time required to restore preoperative body weight

Key secondary outcomes

Unine output
Total amount of furosemide given
Incidence of worsening renal function (WRF)
Incidence of postoperative atrial fibrillation (new onset)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Oral administration of tolvaptan starting postoperative day 1.
Tolvaptan is given until the body weight restores preoperative level or maximum 5 days.

Interventions/Control_2

Conventional postoperative fluid management using oral and/or intravenous furosemide

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Adult patients who underwent cardiac surgery using cardiopulmonary bypass

Key exclusion criteria

Renal insufficiency (Serum creatinine level > 3.0 mg/dl or on chronic dialysis)
Serum Na level > 147 mEq/L on postoperative day 1

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Motonobu Nishimura

Organization

Tottori University Hospital

Division name

Cardiovascular Surgery

Zip code


Address

36-1 Nishi-cho, Yonago, Tottori, Japan

TEL

0859-38-6577

Email

nishimur@med.tottori-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Motonobu Nishimura

Organization

Tottori University Hospital

Division name

Cardiovascular Surgery

Zip code


Address

36-1 Nishi-cho, Yonago, Tottori, Japan

TEL

0859-38-6577

Homepage URL


Email

nishimur@med.tottori-u.ac.jp


Sponsor or person

Institute

Division of Cardiovascular Surgery
Tottori University Hospital

Institute

Department

Personal name



Funding Source

Organization

Division of Cardiovascular Surgery
Tottori University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

鳥取大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 11 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.1253/circj.CJ-17-0967

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2018 Year 05 Month 09 Day


Other

Other related information



Management information

Registered date

2017 Year 01 Month 10 Day

Last modified on

2018 Year 05 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029455


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name